4 completed, 2 unknown, 1 not yet recruiting, 1 recruiting. 3 Phase 4, 2 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Unknown 2, Completed 1 |
| Not applicable | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow HDL Cholesterol: new trials by email Literature Review of HDL Cholesterol trials Research Report on HDL Cholesterol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fish Oil and HDL Function in Patients on Maintenance Hemodialysis n-3 PUFA (fish oil) - Kidney Failure Chronic, Cardiovascular Disease | Not applicable | Not yet recruiting | Medical University of Vienna | 40 | 2026-10-01 | 2026-08-04 |
| Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food Bottarga, Comparator - Prediabetes, Diabetes | Not applicable | Recruiting | Cambridge Health Alliance | 20 | 2025-10-17 | 2026-07-16 |
| Identifying HDL Composition and Function in Preeclamptic and Normal Pregnancies HDL Cholesterol, Preeclampsia | Completed | Meir Medical Center | 30 | 2015-09-01 | 2019-09-09 | |
| Effect of Niaspan on Cholesterol in Men HDL Cholesterol | Completed | KineMed | 15 | 2007-12-01 | 2011-06-30 | |
| The Low HDL On Six Weeks Statin Therapy (LOW) Study Nicotinic acid - HDL Cholesterol, Coronary Arteriosclerosis | Phase 4 | Unknown | Craigavon Area Hospital | 60 | 2005-11-01 | 2006-09-13 |
| High-density Lipoprotein (HDL) Cholesterol in Women Taking Tibolone fenofibrate and tibolone, tibolone - HDL Cholesterol | Phase 4 | Completed | Keogh Institute for Medical Research | 20 | 2005-08-01 | 2010-02-02 |
| Crossover of Higher Dose Statins in Patients With Low High-density Lipoproteins Cholesterol (HDLc) Simvastatin, Atorvastatin 80 mg - HDL Cholesterol | Phase 4 | Unknown | Oregon Health and Science University | 80 | 2005-01-01 | 2011-07-22 |
| A Crossover Study to Evaluate the Efficacy of Simvastatin in Elevating HDL-C Levels in Patients With Type 2 Diabetes (0733-216)(COMPLETED) MK0733 / Duration of Treatment: 18 Weeks, Comparator: placebo (unspecified) / Duration of Treatment: 18 Weeks - HDL Cholesterol | Phase 3 | Completed | Organon and Co | 150 | 2001-07-26 | 2024-08-15 |
Inflammation (2) · Atherosclerosis (1) · Cardiovascular Diseases (1) · Coronary Artery Disease (1) · Diabetes Mellitus (1) · Glucose Intolerance (1) · Hypercholesterolemia (1) · Hyperlipidemias (1) · Obesity (1) · Overweight (1) · Pre-Eclampsia (1) · Prediabetic State (1) · Renal Insufficiency, Chronic (1)
Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Arterial Occlusive Diseases (2) · Arteriosclerosis (2) · Cardiovascular Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Urogenital Diseases (2) · Vascular Diseases (2) · Body Weight (1) · Chronic Disease (1) · Coronary Disease (1) · Disease Attributes (1) · Dyslipidemias (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1)
Atorvastatin (1) · Duration of Therapy (1) · Fatty Acids, Omega-3 (1) · Fenofibrate (1) · Fish Oils (1) · Niacin (1) · Simvastatin (1) · tibolone (1)
Cambridge Health Alliance (1) · Craigavon Area Hospital (1) · Keogh Institute for Medical Research (1) · KineMed (1) · Medical University of Vienna (1) · Meir Medical Center (1) · Oregon Health and Science University (1) · Organon and Co (1)
United States (3) · Australia (1) · Austria (1) · Israel (1) · United Kingdom (1)
Bronwyn G Stuckey, MBBS FRACP (1) · Craig D Williams (1) · Gerald F Watts, MD PhD FRACP (1) · Hugh Barrett, BAgSc PhD (1) · I Menown, MD FRCP (1) · Rosalind Hampton, BSc MBBS (1) · Scott Turner, PhD (1) · Stefanos N Kales, Professor of Medicine, Harvard Medical School, MD (1)
2004 (1)